SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-18
👔
Arcutis Biotherapeutics, Inc.
@ARQT_InsiderForm 4 Filing: LIN SUE-JEAN Sells $120,586.942 of $ARQT
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Arcutis Biotherapeutics, Inc.
Ticker: $ARQT
Transaction Value
$120,586.942
Price/Share: $24.38
transaction date
2026-06-15
Shares: 4,946
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, LIN SUE-JEAN, holds the title of Director at Arcutis Biotherapeutics, Inc..
On 2026-06-15, the insider transacted 4,946 shares.The shares were transacted at a weighted average price of $24.38 per share, resulting in a total market-relevant value of $120,586.942.
Executive Summary Summary
LIN SUE-JEAN (Director) sold $121K of $ARQT
Post-Transaction Position: 27,567 shares
SEC Accession No: 0001628280-26-044083 (CIK: 1867788)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.